drugset / Trial / NCT03658408

4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy

NCT03658408

Phase 2 Withdrawn University of Rochester
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to see if the study drug 4-aminopyridine (4-AP) can help speed up the recovery of peripheral nerve injury after prostatectomy. 4-AP is a potassium channel blocker used to improve walking in multiple sclerosis patients. Investigators will measure the effect that 4-AP may have on the recovery of sexual function and urinary incontinence after prostatectomy.

Timeline

Start
2018-10-03
Primary completion
2018-10-30
Completion
2018-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dalfampridine Small molecule 2.5 mg Oral

Indications